Careers at Provid
|
Contact Us
|
News & Resources
Home
Client Drug Discovery Services & Development
Analysis & Solution Design
Understanding Client Objectives
Problem Solving
Novel IP
Expert Medicinal Chemistry
Hypothesis-driven Research
Lead Discovery & Optimization
Small Molecule Chemistry
Peptides & Peptide Mimetics
Project Management & Drug Development
Exceptional Client Communications
Alliances & Network Coordination
Intellectual & Experimental Due Diligence
Working with Provid
Translational Research
Grant-Funded Projects For Early Stage Research
Internal R&D Progams
Multiple Sclerosis
Other Autoimmune Diseases
Oncology Targets
Drug Development
About Us
Management
Board of Directors
Scientific Advisory
News & Resources
News Archive
Home
>
News & Resources
>
News & Archive
Email Us
Print
News Archive
Provid CEO leads panel at Pharma ChemOutsourcing conference
Provid Announces New National Cancer Institute Contract
Provid Pharmaceuticals Announces Celiac Disease Program and Grant
Provid Pharmaceuticals receives SBIR grant to study role of Provid compounds in cardiac function
Provid Pharmaceuticals receives NIH grant to fund multiple sclerosis research
Provid Pharmaceuticals selected for hit-to-lead and lead optimization medicinal chemistry support for National Cancer Institute
